Chai Discovery
Develops AI models for molecular prediction and drug discovery.
aibiotech
Company facts
Series B-stage
- Founded
- 2024
- Employees
- 29
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $130M · 2025
Open positions
1 job


19 views 2 months ago
Scientist, Protein Design
Open 61d North America
United States
San Francisco officeScientist acting as a power user of Chai's AI-driven molecular design platform, partnering with pharmaceutical companies on drug discovery problems and feeding insights back to refine models and product.